Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Link Pharma ChemBOM:524748 +4.12%60 Piotroski F-Score is 7 as of Aug. 01, 2026, which is at its 10-year median of 7.00. GuruFocus rates BOM:524748 with a GF Score™ of 60/100 and a GF Value™ of ₹36.15 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,558 Chemicals companies, Link Pharma Chem ranks better than 89.99% on this metric.
Good Sign:
Piotroski F-Score is 7, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Link Pharma Chem has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Link Pharma Chem's Piotroski F-Score or its related term are showing as below:
BOM:524748'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 7 Max: 8
Current: 7
During the past 13 years, the highest Piotroski F-Score of Link Pharma Chem was 8. The lowest was 3. And the median was 7.
Link Pharma Chem (BOM:524748) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Link Pharma Chem Piotroski F-Score Related Terms
Link Pharma Chem Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Link Pharma Chem's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Link Pharma Chem's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Link Pharma Chem Piotroski F-Score vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Link Pharma Chem's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Link Pharma Chem's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Link Pharma Chem's current Net Income (TTM) was 0.8.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Link Pharma Chem's return on assets of this year was 0.00330141. Link Pharma Chem's return on assets of last year was -0.03958721.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Link Pharma Chem's gearing of this year was 0.02880927. Link Pharma Chem's gearing of last year was 0.01695253.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Link Pharma Chem's current ratio of this year was 1.00877989. Link Pharma Chem's current ratio of last year was 1.11015937.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Link Pharma Chem's number of shares in issue this year was 4.441. Link Pharma Chem's number of shares in issue last year was 4.441.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Link Pharma Chem's gross margin of this year was 0.53394384. Link Pharma Chem's gross margin of last year was 0.44137237.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Link Pharma Chem's asset turnover of this year was 1.17762771. Link Pharma Chem's asset turnover of last year was 0.98008116.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
0
+
0
+
1
+
1
+
1
=
7
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Link Pharma Chem has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
Link Pharma Chem (BOM:524748) has a Piotroski F-Score of 7 as of Aug. 01, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Link Pharma Chem and its competitors. This is near median its historical median of 7.00. Over the past decade, Link Pharma Chem's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Link Pharma Chem ranks #156 out of 1558 companies in the Chemicals industry, placing it in the top 10%.
Is Link Pharma Chem's Piotroski F-Score too high?
Link Pharma Chem's current Piotroski F-Score of 7 is near median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Chemicals industry median Piotroski F-Score is 5.00. Link Pharma Chem's value of 7 is 40% above this industry median. Based on the distribution chart, Link Pharma Chem ranks #156 out of 1558 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Link Pharma Chem has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Link Pharma Chem's Piotroski F-Score compare to DOW?
According to the Chemicals industry distribution chart, Link Pharma Chem ranks #156 out of 1558 companies for Piotroski F-Score. This places Link Pharma Chem in the top 10% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Link Pharma Chem's value of 7 is 40% above this benchmark. Historically, Link Pharma Chem's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, Link Pharma Chem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Chemicals company?
The median Piotroski F-Score among Chemicals companies is 5.00, based on 1,558 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Link Pharma Chem's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Link Pharma Chem and its competitors. For the Chemicals industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Link Pharma Chem's current Piotroski F-Score is 7, which is near median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Link Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Link Pharma Chem (BOM:524748) is currently considered Possible Value Trap. The stock's GF Value™ is ₹36.15, compared to a current price of ₹25.00 — trading 30.8% below its estimated fair value. The current Piotroski F-Score is 7, which is near median its 10-year median of 7.00 and 40% above the Chemicals industry median of 5.00. Link Pharma Chem's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Link Pharma Chem (BOM:524748), the current Piotroski F-Score is 7 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Link Pharma Chem (BOM:524748) Overvalued in 2026?
Based on GuruFocus' analysis, Link Pharma Chem stock appears to be undervalued.
The current stock price of ₹25.00 is trading 30.8% below its estimated GF Value™ of ₹36.15.
GuruFocus considers Link Pharma Chem to be Possible Value Trap.
Key valuation signals for BOM:524748:
Piotroski F-Score: 7 (near median its 10-year median of 7.00)
GF Value™: ₹36.15 vs. price of ₹25.00 (30.8% below fair value)
Industry Position: 40% above the Chemicals median (#156 of 1558)
No single metric tells the full story. See the BOM:524748 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Link Pharma Chem Ltd is engaged in the manufacturing and selling of organic intermediates which are used in pharmaceuticals, agro and speciality chemical industries. The company has its manufacturing location at Nandesari in Gujarat. It operates through single segment which is Chemical manufacturing and generates revenue from the same. The company generates the majority of its revenue from domestic sales.
60GF Score
Get the complete analysis for BOM:524748
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524748 has been successfully added to your 
